Please login to the form below
biologic
This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.
NICE’s fast-track catapults Skyrizi into market
Dr Alice Butler, UK medical director, AbbVie confirmed last month that Skyrizi’s NICE fast-track appraisal would make it the fastest ever market access approval for any psoriasis biologic treatment.
Latest news
-
Leo Pharma to market AstraZeneca’s brodalumab outside Europe
At that time, it was the first and only biologic drug that targets the IL-17 receptor.
-
White House unveils plans to reimport medicines from Canada
The plan would allow the import of of certain categories of lower cost drugs from Canada, but would exclude all biologic drugs (including insulin), intravenous drugs and controlled substances.
-
Takeda makes Crohn’s disease case for subcutaneous Entyvio
biologic drug.
-
AbbVie’s Skyrizi gets rapid ‘yes’ from NICE
Risankizumab’s availability on the NHS will represent the fastest time between marketing authorisation and reimbursement of any biologic treatment for psoriasis,” commented Dr Alice Butler, UK medical director, AbbVie.
-
FDA will maintain the pace, vows Woodcock, but warns of skills gap
and biologic approvals. ... However Woodcock warned that this new approach could bring with it a number of challenges, not least its own Center for Biologics Evaluation and Research (CBER) struggling to meet demand from
More from news
Approximately 18 fully matching, plus 543 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare
That’s why Theodora Hall taking on the top job at emerging UK biotech Crescendo Biologics is worth noting, as she represents a new generation of leaders in the sector.
-
Transitions in healthcare
Switching from an originator biologic to a cheaper biosimilar. These are all examples of the kind of treatment transitions patients experience that can be supported by Patient Support Programmes.
-
Brain power: fresh approaches to Alzheimer’s drug discovery
These trials aim to accommodate phase 2-ready small molecule or biologic candidates.
-
NHS regional footprints
biologics and joint replacement.
-
Is China ready for a pharmaceutical gold rush?
On top of that, several local firms including Junshi Biosciences, Innovent Biologics and Hengrui Medicine, are developing their own PD-1 I-O treatments that are expected to hit the market ... Innovent Biologics Inc raised HK$3.3bn ($421m) at a valuation
More from intelligence
Approximately 3 fully matching, plus 75 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... A champion for science and
-
BMS appoints new commercial leader, Davies joins Eisai and more
Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.
-
Industry appointments
Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
-
Nabriva Therapeutics appoints chief medical officer
medical affairs for small molecules and biologics.
-
Ipsen appoints Aidan Murphy as EVP, technical operations
He is promoted from senior VP biologics development and manufacturing. Ipsen has added to its executive leadership team in the form of Aidan Murphy, who becomes the biopharma’s executive vice ... being senior vice president biologics development and
More from appointments
Approximately 7 fully matching, plus 46 partially matching documents found.
Latest from PMHub
-
MIT reveals new pill to deliver insulin
Alex:This device enables the delivery of all biologic drugs, not just insulin. ... For example, I confirmed the insulin was still active when pressed into the device and ensured the properties didn’t change considering that we are submitting the
-
Infographic: Rheumatoid arthritis (RA)
An overview of the RA biologic patient. Our RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study.
-
Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)
It is easy to perform and is more rapid than traditional chemical or biologic cell transfection techniques. ... does not negatively alter the biologic structure or function of the target cells.
-
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
-
NHS medicines optimisation milestone
Consequently, it is hugely significant to the NHS’s best value biologics agenda. ... A key issue to consider in this regard is how patients receive biologic medications.
More from PMHub
Approximately 7 fully matching, plus 37 partially matching documents found.
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
OUTiCO
Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
